A study of ruxolitinib cream in patients with lichen planus indicated that the topical JAK inhibitor is a promising potential ...

Lipella Pharmaceuticals’ innovative liposomal drug delivery platform receives US patent: Pittsburgh Wednesday, October 16, 2024, 17:00 Hrs [IST] Lipella Pharmaceuticals Inc., a ...

Patent application covers key technology innovations for delivering therapeutic agentsProprietary technology enables precise delivery to improve safety and efficacy in oncology, cancer survivorship an ...

With the recent patent allowance and ongoing clinical trials, Lipella Pharmaceuticals is poised for significant advancements in its therapeutic offerings. The company’s focus on conditions with high ...

Patent application covers key technology innovations for delivering therapeutic agentsProprietary technology enables precise ...